search
Back to results

STRONG for Surgery & Strong for Life - Against All Odds: Intensive Prehabilitation for Risk Reduction in Cancer Surgery (STRONG-CS)

Primary Purpose

Risk Reduction, Urological Cancer, Surgery

Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Prehabilitation
Sponsored by
Bispebjerg Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Risk Reduction focused on measuring Postoperative complications, Prehabilitation, Surgical risk reduction, Smoking, Alcohol drinking, Physical activity, Malnutrition, Obesity, Patient preferences, Randomised controlled trial

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients > 18 years scheduled for cystectomy due to bladder cancer
  • Referral to neoadjuvant chemotherapy
  • Screened positive for minimum 1 SNAP factor
  • Signed informed consent

Exclusion Criteria:

  • Pregnancy and breastfeeding
  • Allergy to pharmaceutical support (Nicotine Replacement Therapy, Disulfiram)
  • Contraindications to exercise.

Sites / Locations

  • Dept Urology 2112, Copenhagen University Hospital, RigshospitaletRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Prehabilitation

Treatment as usual

Arm Description

Intervention: Patients allocated to the intervention group receive weekly counselling sessions in 6 weeks as an integrated prehabilitation program tailored to meet the individual patient's need for risk reduction at surgery. It is introduced via the surgical 'Engage in the process of change'. The smoking and alcohol cessation intervention follows the Gold Standard Programme and patients in the intervention group are introduced to a standardized exercise training programme taking individualized needs into account. Nutritional support is also individualized.

Treatment as ususal covers shorter interventions, e.g. advice, brief counselling, and handing out the national folders on smoking and alcohol and surgery. Patients are ensured that they are free to access support to lifestyle changes in the community.

Outcomes

Primary Outcome Measures

Number of patients with risk reduction at surgery
Corresponding at least 1 step for 1 or more risky lifestyles (but only smoking in study III) on the ASA-score (American Society of Anaesthesiologists physical status classification from 1-5, lower is better)

Secondary Outcome Measures

Health related quality of life (HRQoL)
Mean difference of HRQoL between groups measured with EQ5D (5 level quality of life score (level 1 =no problems, level 2-5 =problems)
Number of patients with any postoperative complication
Scored by the Comprehensive Complication Index, a linear scale ranging from 0 (no complication) to 100 (death)
Number of successful tobacco quitters
Successful quitting smoking: Study I+ II+ III Successful quitting alcohol intake at 6 weeks and below risky limits at 6 months: Study I. Physical activity at least 30 minutes per day: Study I. Malnutrition: Not at risk of malnutrition: Study I. Obesity: 5% -10 % loss of body fat mass and below 1% gain of body fat mass at 6 months (without developing malnutrition)
Number of successful alcohol quitters
Successful quitting alcohol: Study I+II
Number of patients being physical active at least 30 min per day
Minutes physical active measured by an accelerometer (longer time is better) : Study I+II
Number of patients not at risk of malnutrition
NRS2002 (Nutritional Risk Screening 2002) score>2. Lower is better: Study I+II
Number of patients not at risk of obesity
BMI (Body Mass Index)<30. Lower is better : Study I+II
Number of patients with improved frailty level
Measured by Lammers definition: Lower is better: Study I+II+III
Number of patients with any reduction in lifestyle
Measured by yes/no. Study I+II+III

Full Information

First Posted
July 8, 2019
Last Updated
April 14, 2022
Sponsor
Bispebjerg Hospital
Collaborators
Rigshospitalet, Denmark
search

1. Study Identification

Unique Protocol Identification Number
NCT04088968
Brief Title
STRONG for Surgery & Strong for Life - Against All Odds: Intensive Prehabilitation for Risk Reduction in Cancer Surgery
Acronym
STRONG-CS
Official Title
STRONG for Surgery & Strong for Life - Against All Odds: Intensive Prehabilitation Including Smoking, Nutrition, Alcohol and Physical Activity for Risk Reduction in Cancer Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2022 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Bispebjerg Hospital
Collaborators
Rigshospitalet, Denmark

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Despite knowledge about the effect of preventive measures in lifestyle, smoking,nutrition, alcohol and physical activity (SNAP), there is a lack of systematic assessment of the overall lifestyle of the patient before surgery and knowledge about how lifestyle interventions can be organized in connection with cancer surgery. The intention with prehabilitation is to optimize the individual's risk factors and personal burdens that can affect the clinical and patient reported outcomes after surgery. The aim of this study is to evaluate the efficacy of intensive SNAP interventions compared to treatment as usual (TAU) in ptt undergoing urological cancer surgery on surgical risk reduction.
Detailed Description
The project contains three clinical intervention studies, in total including 100 urological cancer patients screened positive for at least 1 SNAP factor: I. Efficacy and preferences of intensive SNAP-Interventions among patients with at least one SNAP factor and undertaking neo-adjuvant chemotherapy before radical cystectomy. A randomised controlled trial with nested interviews (42 patients). II. Implementation and preferences of intensive SNAP-Interventions among patients with kidney cancer undergoing nephrectomy/partial nephrectomy. An implementation feasibility study including interviews (38 patients). III. Reach out and effect as well as preferences of perioperative intensive smoking cessation intervention via the municipality clinic compared to the surgical department among smokers with non-invasive bladder cancer treated with Trans-Urethral Resection of the Bladder (TUR-B). A randomised controlled trial with nested interviews (20 patients). The intervention groups receive minimum five educational sessions tailored to individual needs over six weeks perioperatively. The control groups receive standard care.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Risk Reduction, Urological Cancer, Surgery, Life Style
Keywords
Postoperative complications, Prehabilitation, Surgical risk reduction, Smoking, Alcohol drinking, Physical activity, Malnutrition, Obesity, Patient preferences, Randomised controlled trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomised Controlled Trials, Implementation feasibilty trial, Interviews nested
Masking
Outcomes Assessor
Masking Description
Outcome assessors will not know if patients were allocated to intervention or control group
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Prehabilitation
Arm Type
Experimental
Arm Description
Intervention: Patients allocated to the intervention group receive weekly counselling sessions in 6 weeks as an integrated prehabilitation program tailored to meet the individual patient's need for risk reduction at surgery. It is introduced via the surgical 'Engage in the process of change'. The smoking and alcohol cessation intervention follows the Gold Standard Programme and patients in the intervention group are introduced to a standardized exercise training programme taking individualized needs into account. Nutritional support is also individualized.
Arm Title
Treatment as usual
Arm Type
No Intervention
Arm Description
Treatment as ususal covers shorter interventions, e.g. advice, brief counselling, and handing out the national folders on smoking and alcohol and surgery. Patients are ensured that they are free to access support to lifestyle changes in the community.
Intervention Type
Behavioral
Intervention Name(s)
Prehabilitation
Other Intervention Name(s)
smoking cessation, alcohol cessation, physical activity, nutritional support for malnutrition and obesity
Intervention Description
Patients screened positive for minimun 1 SNAP factor will be offered enrollment in the study and have an individualized plan for the prehabilitation intervention.
Primary Outcome Measure Information:
Title
Number of patients with risk reduction at surgery
Description
Corresponding at least 1 step for 1 or more risky lifestyles (but only smoking in study III) on the ASA-score (American Society of Anaesthesiologists physical status classification from 1-5, lower is better)
Time Frame
End of intervention/ at surgery
Secondary Outcome Measure Information:
Title
Health related quality of life (HRQoL)
Description
Mean difference of HRQoL between groups measured with EQ5D (5 level quality of life score (level 1 =no problems, level 2-5 =problems)
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months
Title
Number of patients with any postoperative complication
Description
Scored by the Comprehensive Complication Index, a linear scale ranging from 0 (no complication) to 100 (death)
Time Frame
30 days
Title
Number of successful tobacco quitters
Description
Successful quitting smoking: Study I+ II+ III Successful quitting alcohol intake at 6 weeks and below risky limits at 6 months: Study I. Physical activity at least 30 minutes per day: Study I. Malnutrition: Not at risk of malnutrition: Study I. Obesity: 5% -10 % loss of body fat mass and below 1% gain of body fat mass at 6 months (without developing malnutrition)
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months
Title
Number of successful alcohol quitters
Description
Successful quitting alcohol: Study I+II
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months
Title
Number of patients being physical active at least 30 min per day
Description
Minutes physical active measured by an accelerometer (longer time is better) : Study I+II
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months
Title
Number of patients not at risk of malnutrition
Description
NRS2002 (Nutritional Risk Screening 2002) score>2. Lower is better: Study I+II
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months
Title
Number of patients not at risk of obesity
Description
BMI (Body Mass Index)<30. Lower is better : Study I+II
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months
Title
Number of patients with improved frailty level
Description
Measured by Lammers definition: Lower is better: Study I+II+III
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months
Title
Number of patients with any reduction in lifestyle
Description
Measured by yes/no. Study I+II+III
Time Frame
6 weeks/day at surgery, at 1 month and through study completion, an average of 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients > 18 years scheduled for cystectomy due to bladder cancer Referral to neoadjuvant chemotherapy Screened positive for minimum 1 SNAP factor Signed informed consent Exclusion Criteria: Pregnancy and breastfeeding Allergy to pharmaceutical support (Nicotine Replacement Therapy, Disulfiram) Contraindications to exercise.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hanne Tønnesen, Professor MD
Phone
+4538163840
Email
hanne.tonnesen@regionh.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Susanne V Lauridsen, PhD
Phone
+4535451704
Email
susanne.vahr.lauridsen@regionh.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hanne Tonnesen, Professor MD
Organizational Affiliation
WHOCC, The Parker Institute, Bispebjerg-Frederiksberg Hospital, RegH, Copenhagen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Dept Urology 2112, Copenhagen University Hospital, Rigshospitalet
City
Copenhagen
State/Province
Region H
ZIP/Postal Code
2100
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Susanne V Lauridsen, PhD
Phone
+4535451704
Email
susanne.vahr.lauridsen@regionh.dk

12. IPD Sharing Statement

Citations:
PubMed Identifier
35449008
Citation
Tonnesen H, Lydom LN, Joensen UN, Egerod I, Pappot H, Lauridsen SV. STRONG for Surgery & Strong for Life - against all odds: intensive prehabilitation including smoking, nutrition, alcohol and physical activity for risk reduction in cancer surgery - a protocol for an RCT with nested interview study (STRONG-Cancer). Trials. 2022 Apr 21;23(1):333. doi: 10.1186/s13063-022-06272-2.
Results Reference
derived

Learn more about this trial

STRONG for Surgery & Strong for Life - Against All Odds: Intensive Prehabilitation for Risk Reduction in Cancer Surgery

We'll reach out to this number within 24 hrs